Menu
Back to User profile » Dr Hongqian Guo
Papers published by Dr Hongqian Guo:
CD8+CD39+ T Cells Mediate Anti-Tumor Cytotoxicity in Bladder Cancer
Zhu W, Zhao Z, Feng B, Yu W, Li J, Guo H, Yang R
OncoTargets and Therapy 2021, 14:2149-2161
Published Date: 25 March 2021
Molecular Heterogeneity of Xp11.2 Translocation Renal Cell Carcinoma: The Correlation Between Split Signal Pattern in FISH and Prognosis
Zhu Y, Pu X, Dong X, Ji C, Guo H, Li D, Zhao X, Gan W
Cancer Management and Research 2021, 13:2419-2431
Published Date: 15 March 2021
Preoperative Risk Classification Using Neutrophil-to-Lymphocyte Ratio and Albumin for Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy
Zhao Z, Xie S, Feng B, Zhang S, Sun Y, Guo H, Yang R
Cancer Management and Research 2020, 12:9023-9032
Published Date: 25 September 2020
Combination chemotherapy with Zyflamend reduced the acquired resistance of bladder cancer cells to cisplatin through inhibiting NFκB signaling pathway
Xue Y, Yang L, Li J, Yan Y, Jiang Q, Shen L, Yang S, Shen B, Huang R, Yan J, Guo H
OncoTargets and Therapy 2018, 11:4413-4429
Published Date: 30 July 2018
Self-assembled albumin nanoparticles for combination therapy in prostate cancer
Lian H, Wu J, Hu Y, Guo H
International Journal of Nanomedicine 2017, 12:7777-7787
Published Date: 24 October 2017
Drug delivery system based on dendritic nanoparticles for enhancement of intravesical instillation
Qiu X, Cao K, Lin T, Chen W, Yuan A, Wu J, Hu Y, Guo H
International Journal of Nanomedicine 2017, 12:7365-7374
Published Date: 10 October 2017
Highly effective photothermal chemotherapy with pH-responsive polymer-coated drug-loaded melanin-like nanoparticles
Zhang C, Zhao X, Guo S, Lin T, Guo H
International Journal of Nanomedicine 2017, 12:1827-1840
Published Date: 7 March 2017